Newsroom Archive

By Admin Roshan

19 Feb: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indications

February 19, 2019 02:30 AM Eastern Standard Time LUGANO, Switzerland–(BUSINESS WIRE)–GT Gain Therapeutics SA today announces that it has closed a €2.5 Million series A …